BioAge Labs (BIOA) Long-Term Investments (2023 - 2026)

BioAge Labs has disclosed Long-Term Investments across 4 years of filings, most recently posting $100000.0 for Q1 2026.

• Long-Term Investments for Q1 2026 came in at $100000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $100000.0 (changed 0.0% YoY), and the FY2025 annual result was $100000.0, changed 0.0% from the prior year.
• Long-Term Investments came in at $100000.0 for Q1 2026 at BioAge Labs, roughly flat from $100000.0 in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $100000.0 in Q4 2023 to a low of $100000.0 in Q4 2023.
• The 4-year median for Long-Term Investments is $100000.0 (2023), against an average of $100000.0.
• Peak annual rise in Long-Term Investments reached 0.0% in 2024, while the deepest fall reached 0.0% in 2024.
• BioAge Labs' Long-Term Investments stood at $100000.0 in 2023, then changed by 0.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025, then changed by 0.0% to $100000.0 in 2026.
• The last three Long-Term Investments figures came in at $100000.0 (Q1 2026), $100000.0 (Q4 2025), and $100000.0 (Q3 2025), per Business Quant data.